BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9192124)

  • 21. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1992 Oct; 34(4):337-43. PubMed ID: 1333781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
    Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
    Schweizer J; Kaulen R; Nierade A; Altmann E
    Vasa; 1997; 26(1):43-6. PubMed ID: 9068264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans.
    Herman RB; Jesudason PJ; Mustafa AM; Husain R; Choy AM; Lang CC
    Br J Clin Pharmacol; 2003 Feb; 55(2):134-8. PubMed ID: 12580984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.
    van Baak MA; Verstappen FT; Oosterhuis B
    Eur J Clin Pharmacol; 1986; 30(4):399-406. PubMed ID: 3743615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate variability effects of an agonist or antagonists of the beta-adrenoceptor assessed with scatterplot and sequence analysis.
    Silke B; Riddell JG
    Clin Auton Res; 1998 Jun; 8(3):145-53. PubMed ID: 9651664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension.
    van Zyl AI; Jennings AA; Bateman ED; Opie LH
    Chest; 1989 Jan; 95(1):209-13. PubMed ID: 2562825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of a short course of three lipid lowering drugs on fat oxidation during exercise in healthy volunteers.
    Head A; Jakeman PM; Kendall MJ; Cramb R; Maxwell S
    Postgrad Med J; 1993 Mar; 69(809):197-203. PubMed ID: 8497434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of potassium and lactate for maximal exercise performance during beta blockade.
    Gullestad L; Dolva LO; Nordby G; Skaaraas K; Larsen S; Kjekshus J
    Scand J Clin Lab Invest; 1989 Oct; 49(6):521-8. PubMed ID: 2574496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenoceptor activity and resting energy metabolism in weight losing cancer patients.
    Hyltander A; Daneryd P; Sandström R; Körner U; Lundholm K
    Eur J Cancer; 2000 Feb; 36(3):330-4. PubMed ID: 10708933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
    Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
    Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise tolerance after beta blockade in recent cardiac transplant recipients.
    Buendía Fuentes F; Almenar Bonet L; Martínez-Dolz L; Sancho-Tello de Carranza MJ; Moro López J; Agüero Ramón-Llin J; Sánchez-Lázaro I; Sánchez-Gómez JM; Raso Raso R; Navarro Manchón J; Salvador Sanz A
    Transplant Proc; 2009; 41(6):2250-2. PubMed ID: 19715889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of the influence of celiprolol, metoprolol and atenolol on pulmonary ventilation in patients with asthma].
    Szmidt M; Minc P; Wasiak W
    Pneumonol Alergol Pol; 1999; 67(9-10):452-61. PubMed ID: 10808389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
    Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE
    Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism.
    Hespel P; Lijnen P; Vanhees L; Fagard R; Fiocchi R; Moerman E; Amery A
    Med Sci Sports Exerc; 1986 Apr; 18(2):186-91. PubMed ID: 3010028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiorespiratory and symptomatic variables during maximal and submaximal exercise in men with stable effort angina: a comparison of atenolol and celiprolol.
    Ray SG; McCann G; Henderson E; MacFarlane N; Christie J; Norrie J; Ford I; Grant S; Dargie HJ
    Eur Heart J; 1994 Nov; 15(11):1566-70. PubMed ID: 7835373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
    Sanderson JE; Chan SK; Yu CM; Yeung LY; Chan WM; Raymond K; Chan KW; Woo KS
    Heart; 1998 Jan; 79(1):86-92. PubMed ID: 9505927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of beta-blockade on exercise capacity in hypertensive subjects: a one-year double-blind study of celiprolol and metoprolol.
    Vyssoulis GP; Kouremetis MT; Valiouli MA; Michaelides AP; Toutouzas PK
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):133-9. PubMed ID: 7786833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.